Dopaminergic drugs for Parkinson disease
Levodopa kinetics and why wearing-off appears, decarboxylase, COMT and MAO-B inhibitors, dopamine agonists and impulse control disorders, amantadine, infusion therapies, and which antiemetics and antipsychotics block dopamine.
Tier 2Medical sciences concept
Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made
At a glance
- Parkinson disease motor signs are classically said to appear after roughly half or more of nigral dopaminergic neurons and about 70% to 80% of striatal dopamine are lost (estimates vary between studies). Every drug here replaces dopamine, slows its breakdown or mimics it.
- Levodopa is the most effective drug. Its short half-life and the loss of presynaptic storage explain motor fluctuations and dyskinesia.
- Dopamine agonists last longer but cause more impulse control disorders, somnolence, oedema and hallucinations.
Loading the rest of the note…
Finished reading?
Sources
- Therapeutic Guidelines: Neurology (Parkinson disease)AU/NZTherapeutic Guidelines Ltd, 2026
- Australian Medicines HandbookAU/NZAustralian Medicines Handbook Pty Ltd, 2026
- International Parkinson and Movement Disorder Society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson's diseaseMovement Disorders (Fox SH et al., 2018;33:1248-66), 2018
- Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients (DOMINION)Archives of Neurology (Weintraub D et al., 2010;67:589-95), 2010
- FDA approves tavapadon (Juvmo) for Parkinson diseaseNeurologyLive, 2026
- APOKYN (apomorphine hydrochloride) prescribing information (contraindication with 5-HT3 antagonists)US National Library of Medicine DailyMed, 2026
- Disease duration and the integrity of the nigrostriatal system in Parkinson's diseaseBrain (Kordower JH et al., 2013;136:2419-31), 2013
- Last updated
- 14 November 2026
What changed
- 14 November 2026 Turnstile bot check on sign-in and signed-out feedback